chr20-59755238-C-T
Variant summary
Our verdict is Benign. Variant got -8 ACMG points: 0P and 8B. BP4_StrongBS2
The NM_080672.5(PHACTR3):c.415C>T(p.Pro139Ser) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000694 in 1,613,842 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_080672.5 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -8 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
PHACTR3 | NM_080672.5 | c.415C>T | p.Pro139Ser | missense_variant | 4/13 | ENST00000371015.6 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
PHACTR3 | ENST00000371015.6 | c.415C>T | p.Pro139Ser | missense_variant | 4/13 | 1 | NM_080672.5 | A1 |
Frequencies
GnomAD3 genomes AF: 0.0000985 AC: 15AN: 152236Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.0000765 AC: 19AN: 248452Hom.: 0 AF XY: 0.0000966 AC XY: 13AN XY: 134538
GnomAD4 exome AF: 0.0000664 AC: 97AN: 1461606Hom.: 0 Cov.: 31 AF XY: 0.0000825 AC XY: 60AN XY: 727134
GnomAD4 genome AF: 0.0000985 AC: 15AN: 152236Hom.: 0 Cov.: 33 AF XY: 0.000134 AC XY: 10AN XY: 74370
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Jun 21, 2022 | The c.415C>T (p.P139S) alteration is located in exon 4 (coding exon 4) of the PHACTR3 gene. This alteration results from a C to T substitution at nucleotide position 415, causing the proline (P) at amino acid position 139 to be replaced by a serine (S). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at